1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Palovarotene dose level 2: new trials by email Literature Review of Palovarotene dose level 2 trials Research Report on Palovarotene dose level 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP) Palovarotene dose level 1, Palovarotene dose level 2, Palovarotene dose level 3 - Fibrodysplasia Ossificans Progressiva | Phase 2 | Completed | Clementia Pharmaceuticals Inc. | 58 | 2014-10-09 | 2025-02-19 |
Myositis Ossificans (1) · Ossification, Heterotopic (1)
Clementia Pharmaceuticals Inc. (1)
Argentina (1) · Australia (1) · France (1) · United Kingdom (1) · United States (1)
PMID 36526263, PMID 37957586, PMID 42770123
2014 (1)